Stock listing

Cytosorbents Corporation

Selected listing: HQE1 · FWB · EUR · DE

Cytosorbents Corporation (Frankfurt:HQE1), Health Technology. Latest release Sep 30, 2026: CytoSorbents Announces New Data Presentations at Upcoming…

HQE1:FWBEURDEUpdated September 25, 2026

Ticker: Frankfurt:HQE1
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Frankfurt
Currency: EUR

About Cytosorbents Corporation

The company focuses on developing innovative therapies to treat critical illnesses using its proprietary blood purification technology. Cytosorbents aims to improve patient outcomes through its advanced medical solutions.

Latest news from Cytosorbents Corporation

CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care

September 29, 2026

CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care

September 30, 2026

CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement

September 23, 2026

CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 10, 2026

CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

September 4, 2026

All Cytosorbents Corporation news →

Events

Replays

Cytosorbents Corporation (CTSO) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 04:30 PM ET
Watch
Cytosorbents Corporation (CTSO) Q1 2026 Earnings Call
Wed, May 13, 2026 · 04:30 PM ET
Watch
Cytosorbents Corporation (CTSO) Q4 2025 Earnings Call
Wed, Mar 25, 2026 · 04:30 PM ET
Watch

Research Cytosorbents Corporation

Cytosorbents Corporation company profile

View the public company page for Cytosorbents Corporation on 6ix.

Cytosorbents Corporation news

Read company news and market updates connected to Cytosorbents Corporation.

Cytosorbents Corporation investor events

Find investor webinars, events, and replay context for Cytosorbents Corporation.